论文部分内容阅读
[目的]探究江苏省昆山市2012年恶性肿瘤死亡率与疾病负担。[方法]昆山市2012年肿瘤死亡数据来源于肿瘤登记。按照中国第五次(2000年)人口普查年龄结构及Segi’s世界人口年龄结构为标准计算中标死亡率和世标死亡率。以伤残调整寿命年(disability adjusted life years,DALY)作为疾病负担评价指标。[结果 ]江苏省昆山市2012年肿瘤粗死亡率为186.42/10万(男性为238.26/10万,女性为134.86/10万);中标死亡率为99.55/10万(男性为125.68/10万,女性为72.10/10万)。恶性肿瘤死亡前10位肿瘤分别为肺癌、胃癌、肝癌、胰腺癌、结直肠癌、食管癌、女性乳腺癌、脑癌、白血病及胆囊癌,占全部肿瘤的87.39%。恶性肿瘤所致DALY为23 514.0个健康生命年,其中男性为12 801.1个健康生命年,女性为10 712.9个健康生命年。恶性肿瘤所致的每千人DALY为32.8/千人,其中男性与女性分别为35.7/千人和29.8/千人。因恶性肿瘤而早亡导致的寿命损失年(years of life lost,YLL)占DALY的比例为71.6%,其中男性为79.3%,女性为62.3%。[结论]肺癌和消化道恶性肿瘤是影响2012年昆山居民生命健康的主要癌种,依据现有条件开展恶性肿瘤预防控制十分必要。
[Objective] To explore the 2012 cancer mortality and disease burden in Kunshan City, Jiangsu Province. [Method] The data of cancer death in Kunshan in 2012 come from tumor registration. According to the age structure of China’s fifth (2000) census and the age structure of Segi’s world population, the successful death rate and the death rate of the deceased person were calculated. Disability-adjusted life years (DALY) were used as indicators of disease burden. [Results] The crude tumor death rate in Kunshan City, Jiangsu Province in 2012 was 186.42 / 100000 (238.26 / 100000 for males and 134.86 / 100000 for females). The successful death rate was 99.55 / 100000 (125.68 / 72.10 per 100 000 women). The top 10 malignant tumor deaths were lung cancer, gastric cancer, liver cancer, pancreatic cancer, colorectal cancer, esophageal cancer, female breast cancer, brain cancer, leukemia and gallbladder cancer, accounting for 87.39% of all tumors. Malignant tumors caused 23 514.0 DALYs, of which 12 801.1 were healthy and 10 712.9 were healthy. Malignant tumors caused a DALY of 32.8 per 1,000 people, of which 35.7 per 1,000 men and 29.8 per 1,000 men, respectively. The proportion of years of life lost (YLL) to DALY caused by premature death from malignant tumors was 71.6%, of which 79.3% were male and 62.3% were female. [Conclusions] Lung cancer and gastrointestinal cancer are the main cancers that affect the life and health of Kunshan residents in 2012. It is necessary to carry out the prevention and control of malignant tumors according to the existing conditions.